Patents by Inventor Birgitte Hjort Guldhammer

Birgitte Hjort Guldhammer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 1-centchroman for the manufacture of a pharmaceutical composition for the treatment of obesity
    Patent number: 6008242
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or-prophylaxis of obesity.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: December 28, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Steven Bain, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia
    Patent number: 5919812
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R1, R4 and R5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R2 and R3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: July 6, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
    Patent number: 5886021
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis.
    Type: Grant
    Filed: August 18, 1997
    Date of Patent: March 23, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Jan Ulrik Weis, Birgitte Hjort Guldhammer
  • Prostatic carcinoma
    Patent number: 5883118
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: March 16, 1999
    Assignee: Nova Nordisk A/S
    Inventors: Michael Shalmi, Niels Dyhr Christensen, Niels Korsgaard, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prevention of cerebral degenerative disorders
    Patent number: 5827873
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: October 27, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
    Patent number: 5780502
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or (tertiary amino)( C.sub.1-6 alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or C.sub.1-6 alkyl, or a pharmaceutically acceptable salt thereof for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome.
    Type: Grant
    Filed: July 8, 1997
    Date of Patent: July 14, 1998
    Assignee: Novo Nordisk A/S
    Inventor: Birgitte Hjort Guldhammer
  • 3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
    Patent number: 5756539
    Abstract: A method of inhibiting one or more psychiatric disorders is disclosed comprising administering a compound of formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, C.sub.1-6, alkyl, C.sub.1-6 alkoxy or (tertiary amino)C.sub.1-6 alkoxy; and R.sup.2 and R.sup.3 are individually hydrogen or C.sub.1-6 alkyl, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: May 26, 1998
    Assignee: Novo Nordis A/S
    Inventors: Birte Kloppenborg Skrumsager, Erik Bardrum Nielsen, Birgitte Hjort Guldhammer
  • Benign prostatic hypertrophy
    Patent number: 5726202
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino) (lower alkoxy); and R.sup.2 and R.sup.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: March 10, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Michael Shalmi, Niels Dyhr Christensen, Niels Korsgaard, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
    Patent number: 5696149
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifiuoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: December 9, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Birgitte Hjort Guldhammer